Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S7LG
|
||||
Former ID |
DNCL002553
|
||||
Drug Name |
ARN-509
|
||||
Synonyms |
Arn-509 (AR inhibitor)
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Phase 3 | [524437] | ||
Company |
Aragon Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H15F4N5O2S
|
||||
Canonical SMILES |
CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CN=C(C(=C<br />4)C(F)(F)F)C#N)F
|
||||
InChI |
1S/C21H15F4N5O2S/c1-27-17(31)13-4-3-11(8-15(13)22)30-19(33)29(18(32)20(30)5-2-6-20)12-7-14(21(23,24)25)16(9-26)28-10-12/h3-4,7-8,10H,2,5-6H2,1H3,(H,27,31)
|
||||
InChIKey |
HJBWBFZLDZWPHF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Drug Resistance Mutation (DRM) | |||||
DRM | DRM Info | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.